136 related articles for article (PubMed ID: 17071037)
21. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
Misaki K; Marukawa K; Hayashi Y; Fukusato T; Minamoto T; Hasegawa M; Yamashita J; Fujisawa H
J Neurosurg; 2005 Mar; 102(2 Suppl):197-206. PubMed ID: 16156230
[TBL] [Abstract][Full Text] [Related]
22. Phases of canonical Wnt signaling during the development of mouse intestinal epithelium.
Kim BM; Mao J; Taketo MM; Shivdasani RA
Gastroenterology; 2007 Aug; 133(2):529-38. PubMed ID: 17681174
[TBL] [Abstract][Full Text] [Related]
23. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.
Gyure KA; Prayson RA
Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292
[TBL] [Abstract][Full Text] [Related]
24. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
25. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
Marsh J; Mukherjee P; Seyfried TN
Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
[TBL] [Abstract][Full Text] [Related]
26. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
Jin T; George Fantus I; Sun J
Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
[TBL] [Abstract][Full Text] [Related]
27. P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine.
Sun J; Khalid S; Rozakis-Adcock M; Fantus IG; Jin T
Oncogene; 2009 Sep; 28(35):3132-44. PubMed ID: 19581924
[TBL] [Abstract][Full Text] [Related]
28. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas.
Audard V; Cavard C; Richa H; Infante M; Couvelard A; Sauvanet A; Terris B; Paye F; Flejou JF
Pancreas; 2008 Jan; 36(1):80-3. PubMed ID: 18192886
[TBL] [Abstract][Full Text] [Related]
29. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
[TBL] [Abstract][Full Text] [Related]
30. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.
Groen RW; Oud ME; Schilder-Tol EJ; Overdijk MB; ten Berge D; Nusse R; Spaargaren M; Pals ST
Cancer Res; 2008 Sep; 68(17):6969-77. PubMed ID: 18757411
[TBL] [Abstract][Full Text] [Related]
31. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
Quasnichka H; Slater SC; Beeching CA; Boehm M; Sala-Newby GB; George SJ
Circ Res; 2006 Dec; 99(12):1329-37. PubMed ID: 17122440
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO
J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of Wnt signaling molecules in ameloblastoma with aberrant nuclear expression of beta-catenin.
Tanahashi J; Daa T; Yada N; Kashima K; Kondoh Y; Yokoyama S
J Oral Pathol Med; 2008 Oct; 37(9):565-70. PubMed ID: 18284543
[TBL] [Abstract][Full Text] [Related]
34. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
[TBL] [Abstract][Full Text] [Related]
36. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms.
Kim WB; Lewis CJ; McCall KD; Malgor R; Kohn AD; Moon RT; Kohn LD
J Endocrinol; 2007 Apr; 193(1):93-106. PubMed ID: 17400807
[TBL] [Abstract][Full Text] [Related]
38. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
Ma L; Teruya-Feldstein J; Bonner P; Bernardi R; Franz DN; Witte D; Cordon-Cardo C; Pandolfi PP
Cancer Res; 2007 Aug; 67(15):7106-12. PubMed ID: 17671177
[TBL] [Abstract][Full Text] [Related]
39. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene.
Yoshida T; Kitaura H; Hagio Y; Sato T; Iguchi-Ariga SM; Ariga H
Exp Cell Res; 2008 Apr; 314(6):1217-28. PubMed ID: 18281035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
